Silicon Valley was going to disrupt capitalism. Now it’s just enhancing it

5760The chances that, in a few years’ time, people will be able to receive basic healthcare without interacting with a technology company became considerably smaller after recent announcements of two intriguing but not entirely unpredictable partnerships.

One is between Alphabet, Google’s parent company, and pharmaceuticals giant GlaxoSmithKline. The two have agreed to form a $715m company to focus on the new field of bioelectronics, which involves developing miniature electrical implants capable of treating a number of chronic diseases.

The other announcement was the results of a major new study of genetic markers associated with depression. It was the product of collaboration between 23andme, a Google-backed personal genetics company, and Pfizer, yet another pharmaceuticals giant. It was the largest study of its kind, drawing on DNA data from more than 450,000 23andMe customers, and this scale comes in handy for companies such as Pfizer.

By Evgeny Morozov | The Guardian

READ MORE

About Peter Coffaro 1149 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*